» Articles » PMID: 38277512

The Effect of Female Body Mass Index on Cumulative Live Birth Rate in Women Undergoing in Vitro Fertilization According to Age

Overview
Specialty General Medicine
Date 2024 Jan 26
PMID 38277512
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to explore the impact of female body mass index (BMI) on cumulative live birth rates (CLBR) in patients treated with in vitro fertilization (IVF) and embryo transfer. A total of 2377 patients who visited the Reproductive Medical Center, Luoyang Maternal and Child Health Hospital from January 2015 to December 2021. The patients underwent the first IVF cycles. According to female BMI, patients were divided into 3 groups, group A: BMI ≤ 18.5 kg/m2 (underweight), group B: BMI: 18.5 to 24.0 kg/m2 (normal), group C: BMI ≥ 24.0 kg/m2 (overweight/obesity). Patient basic parameters and clinical outcomes were compared among these 3 groups. Multivariate logistic regression analysis was used to explore the impact of BMI on CLBR. In all treatment cycles, patients' basic parameters were significantly different among 3 BMI groups. Age of underweight patient was younger than patients in the other 2 groups (28.45 ± 5.32 vs 29.89 ± 5.00 vs 30.74 ± 5.40; P = .000). In addition, number of oocytes retrieved was also significantly higher in group A (11.25 ± 5.97 vs 11.07 ± 5.49 vs 10.52 ± 5.02; P = .000). CLBR in these 3 groups were 66.40%, 65.98%, and 59.14%, respectively. In logistic analysis, overweight/obesity was associated with CLBR in young patients (aOR = 0.822, 95% CI: 0.817-0.957, P = .000). However, in the cycles of older patients, the effect of overweight/obesity on the CLBR was not significant (aOR = 0.986, 95% CI: 0.903-1.027, P > .05). Overweight/obesity is a predictor for CLBR in younger patients (<35 years old), but not in advanced age patients undergoing their first IVF/intracytoplasmic sperm injection treatment cycles.

References
1.
Xue X, Shi W, Zhou H, Tian L, Zhao Z, Zhou D . Cumulative Live Birth Rates According to Maternal Body Mass Index After First Ovarian Stimulation for Fertilization: A Single Center Analysis of 14,782 Patients. Front Endocrinol (Lausanne). 2020; 11:149. PMC: 7160227. DOI: 10.3389/fendo.2020.00149. View

2.
Qu P, Mi Y, Zhao D, Wang M, Dang S, Shi W . Effect of the Interaction Between Pre-pregnancy Body Mass Index and Fresh/Frozen Embryo Transfer on Perinatal Outcomes of Assisted Reproductive Technology-Conceived Singletons: A Retrospective Cohort Study. Front Endocrinol (Lausanne). 2020; 11:560103. PMC: 7546789. DOI: 10.3389/fendo.2020.560103. View

3.
Shigiyama F, Kumashiro N, Rikitake T, Usui S, Saegusa M, Kitamura M . A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin. Endocr J. 2016; 63(2):193-8. DOI: 10.1507/endocrj.EJ15-0548. View

4.
Niederberger C, Pellicer A, Cohen J, Gardner D, Palermo G, ONeill C . Forty years of IVF. Fertil Steril. 2018; 110(2):185-324.e5. DOI: 10.1016/j.fertnstert.2018.06.005. View

5.
Shrestha D, La X, Feng H . Comparison of different stimulation protocols used in in vitro fertilization: a review. Ann Transl Med. 2015; 3(10):137. PMC: 4486909. DOI: 10.3978/j.issn.2305-5839.2015.04.09. View